BioSpace News Archive

BioForest

Sana Bio’s $150 Million IPO Expected to Provide Market Valuation of $10 Billion

Despite its lofty valuation, the company does not yet have any drugs in the clinic, although it expects to submit Investigational New Drug applications in 2022 and 2023.

January 18, 2021
·
3 min read
·
Mark Terry
LexaGene Launches EUA Tests for Microfluidic PCR Device in Point-of-Care Facilities

LexaGene has begun a series of studies aimed to bring its MiQLab from research-only use to point-of-care use to detect the SARS-CoV-2 virus.

January 18, 2021
·
4 min read
·
Gail Dutton
FDA

Enhertu Snags FDA Approval for HER2-Positive Gastric Cancer Patients

Daiichi Sankyo’s and AstraZeneca’s Enhertu (fam-trastuzumab deruxtecan-nxki) has become the first HER2-directed medication approved to treat gastric cancer in the U.S. in 10 years.

January 18, 2021
·
2 min read
·
Alex Keown
n-Lorem Foundation Preps First Doses to Treat Ultra-Rare Disease Patients for Free

n-Lorem Foundation has taken on a challenge that many nations consider too great: treating patients with ultra-rare diseases (which affect 30 or fewer people) for free, for life.

January 18, 2021
·
4 min read
·
Gail Dutton
Policy

Pfizer CEO Backs Biden’s Plan for 100 Million Doses in 100 Days

Will there be enough doses of the two authorized mRNA COVID-19 vaccines to meet the lofty goal of 100 million inoculations within 100 days of the start of Joe Biden’s presidential administration?

January 18, 2021
·
3 min read
·
Alex Keown
FDA

FDA Approves J&J’s Darzalex Faspro for Rare Light Chain Amyloidosis

The U.S. Food and Drug Administration approved Janssen Pharmaceuticals’ Darzalex Faspro for adults with newly diagnosed light chain amyloidosis.

January 18, 2021
·
3 min read
·
Mark Terry
Drug Development

Biohaven’s Prodrug Troriluzole Strikes Out Again, This Time Against Alzheimer’s

Being studied for GAD, OCD, AD and spinocerebellar ataxia, Biohaven’s troriluzole has now struck out in 3 late-stage studies.

January 18, 2021
·
2 min read
·
Kate Goodwin
Acellular Dermal Matrices Market | Remarkable Growth in Application of Acellular Dermal Matrices in General Surgery

Acellular dermal matrices refer to biologically derived products that are lacking cells. Generally, these matrices are derived from many sources including porcine, human, and bovine.

January 18, 2021
·
3 min read
Visceral Pain Treatment Market: Ulcerative Colitis Segment to Witness Significant Growth

Pain is experienced when internal organs and tissues are damaged or injured. Visceral pain occurs due to activation of nociceptors of the thoracic, pelvic, or abdominal viscera.

January 18, 2021
·
8 min read
Osteogenesis Imperfecta Treatment Market: Teriparatide segment to expand significantly

Osteogenesis imperfecta (OI) is a genetic disorder in which the bones fracture (break) easily. Sometimes, the fracture occurs for no known reason.

January 18, 2021
·
5 min read